The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Infectious Diseases

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/infdis/jir699PMID 22180621PMCID PMC3242744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Where to start?

  2022cited by this paper
• The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

  2010cited by this paper
• Clinical management of acute HIV infection: best practice remains unknown.

  2010cited by this paper
• Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

  2010cited by this paper
• The detection of acute HIV infection.

  2010cited by this paper
• No evidence of a change in HIV-1 virulence since 1996 in France

  2009cited by this paper
• Effect of early versus deferred antiretroviral therapy for HIV on survival.

  2009cited by this paper
• Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

  2009cited by this paper
• Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort

  2009cited by this paper
• Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

  2009cited by this paper
• Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands

  2009cited by this paper
• Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment

  2009cited by this paper
• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Lack of Evidence for Changing Virulence of HIV-1 in North America

  2008cited by this paper
• Comparison of Two Rapid Human Immunodeficiency Virus (HIV) Assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for Detection of Recent HIV Seroconversion

  2008cited by this paper
• HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

  2008cited by this paper
• The effect of antiretroviral treatment of different durations in primary HIV infection

  2008cited by this paper
• Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.

  2007cited by this paper
• CD4+ Count–Guided Interruption of Antiretroviral Treatment

  2007cited by this paper
• Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002.

  2007cited by this paper
• Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort

  2007cited by this paper
• Effect of Transient Antiretroviral Treatment during acute HIV Infection: Comparison of the Quest Trial Results with CASCADE Natural History Study

  2007cited by this paper
• A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.

  2006cited by this paper
• Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.

  2006cited by this paper
• Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.

  2006cited by this paper
• CD4+ count-guided interruption of antiretroviral treatment.

  2006cited by this paper
• Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

  2006cited by this paper
• Modification of Rapid Human Immunodeficiency Virus (HIV) Antibody Assay Protocols for Detecting Recent HIV Seroconversion

  2005cited by this paper
• Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985–2002

  2005cited by this paper
• Limited Durability of Viral Control following Treated Acute HIV Infection

  2004cited by this paper
• Does transient HAART during primary HIV-1 infection lower the virological set-point?

  2004cited by this paper
• Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

  2003cited by this paper
• Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.

  2002cited by this paper
• Higher Rate of Toxicity With No Increased Efficacy When Hydroxyurea Is Added to a Regimen of Stavudine Plus Didanosine and Nevirapine in Primary HIV Infection

  2002cited by this paper
• Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection

  2001cited by this paper
• Panel on Clinical Practices for Treatment of HIV Infection

  2000cited by this paper
• Immune control of HIV-1 after early treatment of acute infection

  2000cited by this paper
• The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection.

  2000cited by this paper
• The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.

  1999cited by this paper
• Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 Study Group. Division of AIDS Treatment Research Initiative.

  1998cited by this paper
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper
• Primary HIV-1 Infection: Diagnosis and Prognostic Impact

  1998cited by this paper
• A controlled trial of zidovudine in primary human immunodeficiency virus infection.

  1995cited by this paper

• Acute retroviral syndrome

  2025cites this paper
• Interventions during Early Infection: Opening a Window for an HIV Cure?

  2024cites this paper
• Rapid viral suppression using integrase inhibitors during acute HIV-1 infection

  2024cites this paper
• Impact of Latent M. tuberculosis Infection Treatment on Time to CD4/CD8 Recovery in Acute, Recent, and Chronic HIV Infection

  2023cites this paper
• Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation

  2023cites this paper
• Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption

  2022cites this paper
• Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis

  2021cites this paper
• Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens

  2021cites this paper
• The effect of “universal test and treat” program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia

  2020cites this paper
• Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection–Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study

  2020cites this paper
• Antiretroviral treatment for HIV infection: Swedish recommendations 2019

  2020cites this paper
• Treatment of primary HIV infection: new data for a new era.

  2020cites this paper
• Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.

  2020cites this paper
• Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort.

  2020cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

  2020cites this paper
• Clinical Outcomes and Renal Safety in HIV/AIDS Patients on Tenofovir-containing Regimens in Lesotho

  2019cites this paper
• Clinical trials of antiretroviral treatment interruption in HIV-infected individuals

  2019cites this paper
• Integrase strand-transfer inhibitors for treatment of early HIV infection

  2019cites this paper
• The Diagnosis of HIV: Right Test, Right Interpretation, Right Away

  2019cites this paper
• Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: a multicenter retrospective cohort study.

  2019cites this paper
• Role of Innate Genes in HIV Replication.

  2018cites this paper
• Acute HIV Discovered During Routine HIV Screening With HIV Antigen‐Antibody Combination Tests in 9 US Emergency Departments

  2018cites this paper
• Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.

  2018cites this paper
• Diagnosis and Management of Acute HIV

  2018cites this paper
• Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality

  2018cites this paper
• Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217

  2017cites this paper
• Acute HIV-1 infection presenting with fulminant encephalopathy

  2017cites this paper
• Molecular Testing for Human Imunodeficiency Virus

  2017cites this paper
• Antiretroviral treatment for HIV infection: Swedish recommendations 2016

  2017cites this paper
• Fluorescence Reporter in Staphylococcus aureus as a Useful Tool for Studying L-forms and Virulence

  2017cites this paper
• Primary HIV Infection: Clinical Presentation, Testing, and Treatment

  2017cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV

  2017cites this paper
• Ending the epidemic: Critical role of primary HIV infection.

  2017cites this paper
• The costs of HIV treatment and care in Ghana

  2017cites this paper
• IMMUNOLOGICAL TESTS AND DIAGNOSTICS OF ACUTE HIV INFECTION ЛАБОРАТОРНАЯ ДИАГНОСТИКА

  2017cites this paper
• Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.

  2017cites this paper
• Optimal control therapy and vaccination for special HIV-1 model with delay

  2016cites this paper
• Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection

  2016cites this paper
• Barriers to HIV testing, linkage to care, and treatment adherence: a cross-sectional study from a large urban center of Brazil.

  2016cites this paper
• The validity of the biological eligibility criteria to antiretroviral treatment in comparison to the systematic antiretroviral treatment in a cohort of people living with the HIV in the Southern Kivu Province, Democratic Republic of the Congo

  2016cites this paper
• Primary HIV infection: a medical and public health emergency requiring rapid specialist management.

  2016cites this paper
• Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability

  2016cites this paper
• How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection?

  2016cites this paper
• Barriers along the care cascade of HIV-infected men in a large urban center of Brazil

  2016cites this paper
• The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV?

  2016cites this paper
• Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria

  2016cites this paper
• The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment

  2016cites this paper
• Understanding the acceptability and utility of early antiretroviral therapy to reduce transmission of HIV amongst men who have sex with men in the UK

  2016cites this paper
• Accelerated CD4+ cell count decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic

  2016cites this paper
• Human Immunodeficiency Viruses

  2015cites this paper
• How can we better identify early HIV infections?

  2015cites this paper
• HIV-1Suppression of Dendritic Cell Maturation by SAMHD1 Degradation Enhances Active

  2015cites this paper
• Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?

  2015cites this paper
• A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection

  2015cites this paper
• Acute Infections, Cost per Infection and Turnaround Time in Three United States Hospital Laboratories Using Fourth-Generation Antigen-Antibody Human Immunodeficiency Virus Immunoassays

  2015cites this paper
• Exploring the Impact of Antiretroviral Drugs on the Cell-to-Cell spread of HIV-1

  2015cites this paper
• Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.

  2015cites this paper
• Post-treatment control: A functional cure for HIV

  2015cites this paper
• No evidence of posttreatment control after early initiation of antiretroviral therapy

  2015cites this paper
• Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

  2015cites this paper
• Antiretroviral Therapy: When to Start

  2015cites this paper
• SAMHD1 Degradation Enhances Active Suppression of Dendritic Cell Maturation by HIV-1

  2015cites this paper
• HEFFICON: HIV Effectiveness Italian Conference.

  2015cites this paper
• Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?

  2015cites this paper
• Disease progression of HIV-1 infection in symptomatic and asymptomatic seroconverters in Osaka, Japan: a retrospective observational study

  2015cites this paper
• CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies.

  2015cites this paper
• Comparative effectiveness of immediate antiretroviral therapy versus CD 4-based initiation in HIV-positive individuals in high-income countries : observational cohort study

  2015influential citation
• Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

  2015cites this paper
• Editorial Commentary: Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?

  2015cites this paper
• Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy

  2015cites this paper
• The HIV treatment cascade in acutely infected people: informing global guidelines

  2015cites this paper
• HIV Testing Updates and Challenges: When Regulatory Caution and Public Health Imperatives Collide

  2015cites this paper
• Laboratory testing for the diagnosis of HIV infection : updated recommendations

  2014cites this paper
• Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations.

  2014cites this paper
• Antiretroviral therapy: when to start.

  2014cites this paper
• Etude de l’établissement des réservoirs VIH lors de la primo-infection et de l’impact des traitements antirétroviraux très précoces sur ces réservoirs

  2014cites this paper
• Facteurs associés à la réponse au traitement antirétroviral de 55 patients pris en charge entre 2003 et 2013 pour une primo-infection par le virus de l’immunodéficience humaine

  2014cites this paper
• Effet d’un court traitement antirétroviral durant la primo-infection au VIH

  2014cites this paper
• Update on antiretroviral treatment during primary HIV infection

  2014cites this paper
• A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression

  2014cites this paper
• Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment

  2014cites this paper
• Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells

  2014cites this paper
• HIV/AIDS – A Model of Chronic Oxidative Stress and Immune Activation

  2014cites this paper
• Treatment of primary HIV infection

  2013cites this paper
• Acute HIV-1 Infection: A Call to Action

  2013cites this paper
• No change in viral set point or CD4 cell decline among antiretroviral treatment‐naïve, HIV‐1‐infected individuals enrolled in the Danish HIV Cohort Study in 1995–2010

  2013cites this paper
• When to start antiretroviral therapy: as soon as

  2013cites this paper
• Short-course antiretroviral therapy in primary HIV infection.

  2013cites this paper
• Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

  2013cites this paper
• [Consensus Statement by GeSIDA/National AIDS Plan Secretariat on antiretroviral treatment in adults infected by the human immunodeficiency virus (Updated January 2013)].

  2013cites this paper
• When to start antiretroviral therapy: as soon as possible

  2013cites this paper
• Benefits of Antiretroviral Therapy Reduction in Mortality and / or AIDS-Related Morbidity According to Pretreatment CD 4 Cell Count

  2013cites this paper
• Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection

  2013cites this paper
• Immunological and Virological Benefits Resulted from Short-Course Treatment during Primary HIV Infection: A Meta-Analysis

  2013cites this paper
• The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).

  2013cites this paper
• Challenges of Diagnosing Acute HIV-1 Subtype C Infection in African Women: Performance of a Clinical Algorithm and the Need for Point-of-Care Nucleic-Acid Based Testing

  2013cites this paper
• Short-course antiretroviral therapy in primary HIV infection.

  2013cites this paper
• The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) Treatment of primary HIV infection

  2013cites this paper
• Acute Human Immunodeficiency Virus Infection

  2013cites this paper